Legacy Financial Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,620	Closed	-$293K	–	366
2024 Q2	$293K	Sell	22,620 -2,713	-11%	-$35.9K	0.05%	259
2024 Q1	$352K	Buy	25,333 +596	+2%	+$8.67K	0.06%	223
2023 Q4	$353K	Sell	24,737 -812	-3%	-$11.5K	0.07%	207
2023 Q3	$395K	Buy	25,549 +834	+3%	+$12.9K	0.08%	169
2023 Q2	$388K	Buy	24,715 +362	+1%	+$5.93K	0.07%	167
2023 Q1	$401K	Buy	24,353 +861	+4%	+$13.7K	0.08%	153
2022 Q4	$366K	Sell	23,492 -6,142	-21%	-$85.8K	0.08%	150
2022 Q3	$384K	Buy	29,634 +9,264	+45%	+$129K	0.09%	127
2022 Q2	$286K	Buy	20,370 +17	+0.1%	+$243	0.07%	154
2022 Q1	$291K	Buy	+20,353	New	+$299K	0.07%	164
2019 Q2	–	Sell	-300	Closed	-$6K	–	805
2019 Q1	$6K	Buy	+300	New	+$6.04K	﹤0.01%	747